October 19, 2011 Enrique Carrazana, M.D. White Plains, NY 10601 Dear Dr. Carrazana:Acorda Therapeutics Inc • February 28th, 2012 • Biological products, (no disgnostic substances) • New York
Company FiledFebruary 28th, 2012 Industry JurisdictionWe are delighted to present this letter agreement (the “Agreement”), setting out certain severance benefits available to you in the event of a change in control of Acorda Therapeutics, Inc. (the “Company”). If these terms are acceptable, please sign the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of the date written above (the “Effective Date”).
November 7, 2011 Lauren Sabella Fairfield, CT 06825 Dear Lauren:Acorda Therapeutics Inc • February 28th, 2012 • Biological products, (no disgnostic substances) • New York
Company FiledFebruary 28th, 2012 Industry JurisdictionWe are delighted to present this letter agreement (the “Agreement”), setting out certain severance benefits available to you in the event of a change in control of Acorda Therapeutics, Inc. (the “Company”). If these terms are acceptable, please sign the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of the date written above (the “Effective Date”).